Shepherd Kaplan Krochuk’s Biogen BIIB Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,600	Closed	-$952K	–	246
2017 Q1	$984K	Buy	+3,600	New	+$1.02M	0.51%	44

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Shepherd Kaplan Krochuk's BIIB Position: Q2 2017 in Review

Shepherd Kaplan Krochuk sold out of Biogen (BIIB) in Q2 2017, closing a stake of 3,600 shares — an estimated $952K sold.

Shepherd Kaplan Krochuk first reported a position in BIIB in Q1 2017 and held it in 1 quarter. The position peaked at $984K in Q1 2017. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

Shepherd Kaplan Krochuk reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 3,600 Biogen shares in Q2 2017, an estimated $952K.
Shepherd Kaplan Krochuk first reported a position in Biogen in Q1 2017 and held it in 1 quarter.
Shepherd Kaplan Krochuk's Biogen position peaked at $984K in Q1 2017.
992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2017, filed 10 Aug 2017.